FDA to Review Atezolizumab for the Treatment of Non-Small Cell Lung Cancer
Roche has recently been granted priority review by the FDA, who has also accepted their supplemental biologics license application for atezolizumab. Atezolizumab is intended for the treatment of non-small cell…